Masoumeh Amin-Esmaeili, MD, MPH

  • 3Articles
  • 27.6KReads
  • 2021–2023Active
  • 12Collaborators
  • 25Citations

About

Masoumeh Amin-Esmaeili, MD, MPH, is affiliated with the Department of Mental Health at Johns Hopkins Bloomberg School of Public Health in Baltimore, Maryland. The author's publications from 2021 to 2023 focus on major depressive disorder, including the impact of non-psychiatric medications on depressive symptoms, factors influencing participation in suicide-related randomized controlled trials, and strategies for remission and treatment augmentation in depression. Collaborations frequently include Mark Olfson, Ramin Mojtabai, Stanislav Spivak, Allen Zhang, and Hadi Kharrazi.

Publications

JCP
Use of Medication With Depressive Symptom Side Effects
Original Research

Use of Medication With Depressive Symptom Side Effects

May 24, 2023

MDD patients who used non-psychiatric medications with depressive side effects had higher odds of experiencing moderate to severe depressive symptoms.
, , , et al
JCP
Exclusion and Refusal in Youth Suicide Prevention RCTs
Meta-Analysis

Exclusion and Refusal in Youth Suicide Prevention RCTs

February 15, 2022

Ineligibility for and refusal to take part in randomized controlled trials (RCTs) can make samples unrepresentative and limit generalizability of findings. This meta-analysis estimated the exclusion and refusal rates...
, , , et al
JCP
Original Research

Remission and Treatment Augmentation of Depression

November 2, 2021

Closer monitoring of symptoms through measurement-based care and setting symptom remission as a goal can help improve outcomes for adults with depression.
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe